Managing Director, D.E. Shaw and Co., L.P.
Co-Founder and CEO, Wetpaint
CEO and co-founder of BoostSuite
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Prescience International, the firm managing the Janssen Labs life sciences incubator, is hosting an in-depth look at the process of filing a biologic Investigational New Drug (IND) application, and the procedures needed to advance an early stage drug development program. Submitting an IND is a critical milestone for every biotech, regardless of whether the strategy calls for developing a drug all the way through to commercial launch or to partner with a pharmaceutical company as soon as possible. With Big Pharma and venture capital firms competing for the most promising compounds, startups are expected to demonstrate a solid plan for achieving IND acceptance. More information and online registration is here.